CRE24-034: Successful Management of Locally Advanced and Oligometastatic Urothelial Carcinoma With Pembrolizumab-Based Induction Regimen Followed by Consolidative Radical Resection of the Primary Tumor: A Multi-Institutional Case Series. Read more about CRE24-034: Successful Management of Locally Advanced and Oligometastatic Urothelial Carcinoma With Pembrolizumab-Based Induction Regimen Followed by Consolidative Radical Resection of the Primary Tumor: A Multi-Institutional Case Series.
NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024. Read more about NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.
NCCN Guidelines® Insights: Mesothelioma: Pleural, Version 1.2024. Read more about NCCN Guidelines® Insights: Mesothelioma: Pleural, Version 1.2024.
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. Read more about Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Read more about Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024. Read more about NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024. Read more about NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. Read more about Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. Read more about Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
